Overview

• The FDA's approval of Wegovy for adolescents has led to a significant increase in GLP-1 prescriptions among teens, with prescriptions rising over 500% since 2020.
• GLP-1 receptor agonists like Ozempic and Wegovy are noted for their ability to aid weight loss by reducing appetite and improving metabolic health.
• Research suggests these medications may also help reduce cravings associated with substance use disorders, although more clinical studies are needed.
• Despite their benefits, GLP-1 drugs come with potential side effects, including gastrointestinal issues and, in rare cases, more severe health risks.
• Experts emphasize the importance of combining these medications with lifestyle changes, such as diet and exercise, for effective long-term weight management.